Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.23.2
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Accrued liabilities:    
General and administrative $ 317 $ 855
Clinical trial related costs 2,587 1,327
Non-clinical research and manufacturing operations 579 1,779
Payroll related 17 4,828
Other accrued expenses 10 34
Total Accrued liabilities $ 3,510 $ 8,823